MECHOULAM RAPHAEL has a total of 12 patent applications. Its first patent ever was published in 1977. It filed its patents most often in United States, Canada and Israel. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are EDISON PHARMACEUTICALS INC, SIGMA TAU IND FAMACEUTICHE RIU and CALYX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 3 | |
#3 | Israel | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Mechoulam Raphael | 12 |
#2 | Lander Naphtali | 3 |
#3 | Breuer Aviva | 3 |
#4 | Fride Ester | 2 |
#5 | Horowitz Michal | 2 |
#6 | Bab Itai | 2 |
#7 | Tchilibon Susana | 2 |
#8 | Hanus Lumir | 2 |
#9 | Srebnik Morris | 1 |
#10 | Dikstein Shabtay | 1 |
Publication | Filing date | Title |
---|---|---|
WO02070506A2 | Conversion of cbd to δ8-thc and δ9-thc | |
IL132661D0 | Agonists specific for the peripheral cannabinoid receptor |